Your browser doesn't support javascript.
loading
Cytotoxic epimeric ginsenosides from the flower buds of Panax ginseng.
Li, Ke-Ke; Xu, Fei; Li, Sha-Sha; Cao, Gui-Yun; Gong, Xiao-Jie.
Afiliação
  • Li KK; College of Life Science, Dalian Minzu University, Dalian 116600, People's Republic of China. Electronic address: like905219@163.com.
  • Xu F; College of Medical, Dalian University, Dalian 116622, People's Republic of China.
  • Li SS; College of Medical, Dalian University, Dalian 116622, People's Republic of China.
  • Cao GY; Shandong Hongjitang Pharmaceutical Group Co., Ltd., Jinan 250000, People's Republic of China.
  • Gong XJ; College of Life Science, Dalian Minzu University, Dalian 116600, People's Republic of China. Electronic address: gxjclr@163.com.
Steroids ; 143: 1-5, 2019 03.
Article em En | MEDLINE | ID: mdl-30543815
ABSTRACT
Three pairs of ginsenoside epimers, including three new compounds (2, 3 and 5), were isolated from the flower buds of Panax ginseng. The structures of the isolated compounds were elucidated on the basis of considerable spectroscopic analyses and comparison with the reported data. All six compounds were evaluated for their cytotoxicties against three human cancer cell lines, HL-60, MGC80-3 and Hep-G2. Compounds 1, 3, and 6 with S configurations at C-24 or C-20 showed moderate inhibitory activities with IC50 values of 25.32, 18.76, and 38.64 µM in HL-60 cells, respectively. Our findings showed that different configurations of these isolated ginsenosides had a significant impact on the antitumor activity, and S epimers were higher than R.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Flores / Ginsenosídeos / Panax / Antineoplásicos Limite: Humans Idioma: En Revista: Steroids Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Flores / Ginsenosídeos / Panax / Antineoplásicos Limite: Humans Idioma: En Revista: Steroids Ano de publicação: 2019 Tipo de documento: Article